MedTrace Logo

IMRT Versus 3DCRT for Locally Advanced Rectal Cancer, Prospective Phase II Study.

NCT06160570 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2023-12-07

No results posted yet for this study

Summary

The goal of this prospective phase II study was to determine whether personalized planning-based nCRT for LARC would indeed decrease small bowel dose, and whether selected plans, specifically prioritizing lower dose to small bowel, would result in lower rates of acute GI toxicity compared with previously reported rates.

Conditions

Interventions

RADIATION

Intensive Modulated Radiation Therapy

Radiotherapy technique: IMRT

RADIATION

3-Dimension Conformal Radiation Therapy

Radiotherapy technique: 3DCRT

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Yulia Kundel, MD · Davidoff Cancer Center, Rabin Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06160570 on ClinicalTrials.gov